Global POC Glycated Hemoglobin Analyzer Market Growth 2025-2031

The global POC Glycated Hemoglobin Analyzer market size is predicted to grow from US$ 723 million in 2025 to US$ 1088 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.

POC Glycated Hemoglobin Analyzer is the Point-of-care Glycated Hemoglobin Analyzer, which is defined as a medical diagnostic analyzer at or near the point of care—that is, at the time and place of patient care.

Glycated hemoglobin (HbA1c) levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

The classification of POC Glycated Hemoglobin Analyzer includes Bench-top, Compact, Portable, and the proportion of bench-top is about 49%.

POC Glycated Hemoglobin Analyzer is widely used in hospitals, labs and other place. The most proportion of POC Glycated Hemoglobin Analyzer is used in hospitals, and the proportion is about 52%.

Europe is the largest supplier of POC Glycated Hemoglobin Analyzer, with a production market share nearly 48%. North Amerca is the second largest supplier of POC Glycated Hemoglobin Analyzer, enjoying production market share nearly 33%.

North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.

Market competition is not intense. Alere, Siemens, Roche, Trinity Biotech, GREEN CROSS MEDIS and EKF Diagnostics, etc. are the leaders of the industry, with about 70% market shares.

LP Information, Inc. (LPI) ' newest research report, the “POC Glycated Hemoglobin Analyzer Industry Forecast” looks at past sales and reviews total world POC Glycated Hemoglobin Analyzer sales in 2024, providing a comprehensive analysis by region and market sector of projected POC Glycated Hemoglobin Analyzer sales for 2025 through 2031. With POC Glycated Hemoglobin Analyzer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POC Glycated Hemoglobin Analyzer industry.

This Insight Report provides a comprehensive analysis of the global POC Glycated Hemoglobin Analyzer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POC Glycated Hemoglobin Analyzer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POC Glycated Hemoglobin Analyzer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POC Glycated Hemoglobin Analyzer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POC Glycated Hemoglobin Analyzer.

This report presents a comprehensive overview, market shares, and growth opportunities of POC Glycated Hemoglobin Analyzer market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Bench-Top
Compact
Portable

Segmentation by Application:
Hospital
Lab
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alere
Siemens
Roche
Trinity Biotech
GREEN CROSS MEDIS
EKF Diagnostics
OSANG Healthcare
HUMAN Diagnostics
Erba Diagnostics
PTS Diagnostics
Liteon Technology
DiaSys Diagnostic
Convergent Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global POC Glycated Hemoglobin Analyzer market?

What factors are driving POC Glycated Hemoglobin Analyzer market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do POC Glycated Hemoglobin Analyzer market opportunities vary by end market size?

How does POC Glycated Hemoglobin Analyzer break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.